CD90.2 (Thy-1.2) Antibody Super Bright 436 62-0903-82 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

Flow

C57BL/6 mouse splenocytes were stained with CD3 Monoclonal Antibody, APC (Product # 17-0031-82) and 0.25 µg of Rat IgG2b kappa Isotype Control, Super Bright 436 (Product # 62-4031-82) (left) or 0.25 µg of CD90.2 Monoclonal Antibody, Super Bright 436 (right). Cells in the lymphocyte gate were used for analysis.
Flow

C57BL/6 mouse splenocytes were stained with CD3 Monoclonal Antibody, APC (Product # 17-0031-82) and 0.25 µg of Rat IgG2b kappa Isotype Control, Super Bright 436 (Product # 62-4031-82) (left) or 0.25 µg of CD90.2 Monoclonal Antibody, Super Bright 436 (right). Cells in the lymphocyte gate were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
CD90.2 (Thy-1.2) Antibody Super Bright 436

Thermo Fisher Scientific's CD90.2 (Thy-1.2) Antibody Super Bright 436 is a Rat monoclonal antibody. The CD90.2 (Thy-1.2) Antibody Super Bright 436 was generated using Thy1 as the antigen. It reacts with Mouse. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD90.2 (Thy-1.2) Antibody Super Bright 436
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number62-0903-82
Quantity100 µg
ApplicationsFlow Cytometry
Concentration0.2 mg/mL
Conjugate/TagSuper Bright™ 436
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
PurityAffinity chromatography
ReactivityMouse
TargetCD90.2 (Thy-1.2)
IsotypeIgG2b kappa
Clone30-H12
HostRat
NCBI Full Gene Namethymus cell antigen 1, theta
NCBI Gene AliasesCD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2
ClonalityMonoclonal
Antibody TypePrimary
Storage4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Bcl-xL mutant promotes cartilage differentiation of BMSCs by upregulating TGF-β/BMP expression levelsExperimental and therapeutic medicineJuly 1, 2021Xiao K, Yang L, Xie W, Gao X, Huang R, Xie M.

(2) Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disordersNPJ vaccinesJanuary 1, 2020Crouse B, Robinson C, Huseby Kelcher A, Laudenbach M, Abrahante JE, Pravetoni M.

(3) Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosisNature cell biologyAugust 1, 2018Madaro L, Passafaro M, Sala D, Etxaniz U, Lugarini F, Proietti D, Alfonsi MV, Nicoletti C, Gatto S, De Bardi M, et al.

Be the First to Write a Review!